SCHEMBL2938145

SCHEMBL2938145

COc1c(F)c(F)c(-c2c3cc(F)ccc3c(-c3c(F)c(F)cc(F)c3F)c3c(F)ccc(F)c23)c(F)c1F

nearest known ligand 0.31

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.31
TUBB4A P04350 1/20 0.30
TUBB P07437 1/20 0.30
TUBA3C P0DPH7 1/20 0.30
TUBA1B P68363 1/20 0.30
TUBA4A P68366 1/20 0.30
TUBB4B P68371 1/20 0.30
TUBB3 Q13509 1/20 0.30
TUBB2A Q13885 1/20 0.30
TUBB8 Q3ZCM7 1/20 0.30
TUBA3E Q6PEY2 1/20 0.30
TUBA1A Q71U36 1/20 0.30
TUBA1C Q9BQE3 1/20 0.30
TUBB6 Q9BUF5 1/20 0.30
TUBB2B Q9BVA1 1/20 0.30
TUBB1 Q9H4B7 1/20 0.30
NFE2L2 Q16236 1/20 0.30
CYP1A1 P04798 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086224 1.00 HSD17B10 (0.31) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2728454 0.96 HSD17B10 (0.33) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12086237 0.94 HSD17B10 (0.32) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2943822 0.94 HSD17B10 (0.32) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2725964 0.91 HSD17B10 (0.31) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12086148 0.91 HSD17B10 (0.31) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2723537 0.91 TUBB4A (0.33) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12086124 0.91 TUBB4A (0.33) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL2712313 0.88 HSD17B10 (0.32) HSD17B10TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12086136 0.88 HSD17B10 (0.32) HSD17B10TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 HSD17B10 221/4885TUBB4A 426/4885TUBB 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.